14:06 EDT Lixte Biotechnology files $50M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIXT:
- Publication highlighted by Lixte yesterday not new, White Diamond says
- Lixte Biotechnology announces publication on LB-100 in cancer cells
- Lixte Biotechnology provides update on progress with LB-100
- LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments
- Lixte Biotechnology announces presentation of LB-100